Neuroprotection mediated by the EP₄ receptor avoids the detrimental side effects of COX-2 inhibitors following ischaemic injury. [electronic resource]
Producer: 20131017Description: 165-72 p. digitalISSN:- 1873-7064
- Animals
- Brain Ischemia -- pathology
- Cyclooxygenase 2 Inhibitors -- pharmacology
- Hippocampus -- drug effects
- Isoindoles -- pharmacology
- Male
- Mice
- Mice, Inbred C57BL
- Neuroprotective Agents -- pharmacology
- Organ Culture Techniques
- Random Allocation
- Receptors, Prostaglandin E, EP4 Subtype -- agonists
- Sulfonamides -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.